| |
| |
|
| Insider
Information: |
Eshelman Fredric N |
| Relationship: |
10% Owner |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
8,151,654 |
|
|
Indirect Shares
|
3,933,809 |
|
|
| Direct
Value |
$83,566,297 |
|
|
|
Indirect Value
|
$18,625,640 |
|
|
| Total
Shares |
12,085,463 |
|
|
| Total
Value |
$102,191,938 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
7
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -45.7%
|
-43.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2019-12-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,159,744 |
|
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2016-07-01 |
4 |
D |
$23.78 |
$618 |
D/D |
(26) |
17,796 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-06-19 |
4 |
S |
$36.58 |
$3,658 |
D/D |
(100) |
8,600,227 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-06-01 |
4 |
S |
$37.27 |
$7,454 |
D/D |
(200) |
8,600,627 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-03-19 |
4 |
S |
$31.80 |
$9,541 |
D/D |
(300) |
9,017,293 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-07-21 |
4 |
S |
$59.37 |
$41,500 |
D/D |
(699) |
5,060,053 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-05-01 |
4 |
S |
$34.46 |
$31,970 |
D/D |
(900) |
8,767,294 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-09 |
4 |
B |
$16.26 |
$15,398 |
D/D |
947 |
1,611,220 |
3.92 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,096 |
1,096 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2012-05-25 |
4 |
B |
$18.45 |
$26,826 |
D/D |
1,454 |
2,298,889 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2012-05-21 |
4 |
B |
$16.15 |
$38,760 |
D/D |
2,400 |
2,215,435 |
3.92 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-07-16 |
4 |
S |
$38.99 |
$156,255 |
D/D |
(4,004) |
8,350,626 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • • |
2018-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,033 |
1,277,461 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Director |
– • – |
2017-05-03 |
4 |
D |
$9.66 |
$47,373 |
D/D |
(4,904) |
12,892 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2006-05-18 |
4 |
D |
$35.96 |
$194,472 |
D/D |
(5,408) |
9,425,118 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
8,254,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-02-26 |
4 |
S |
$33.31 |
$227,184 |
D/D |
(6,800) |
9,183,960 |
0 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-25 |
4 |
B |
$16.00 |
$108,832 |
D/D |
6,802 |
1,682,282 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-04 |
4 |
B |
$14.92 |
$106,052 |
D/D |
6,922 |
1,353,125 |
3.92 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-04-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
4,957,263 |
|
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2012-03-15 |
4 |
B |
$23.91 |
$169,809 |
D/D |
7,102 |
2,188,035 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
– • • |
2011-11-07 |
4 |
B |
$15.69 |
$112,152 |
D/D |
7,148 |
1,360,273 |
3.92 |
- |
|
| FURX |
Furiex Pharmaceuticals, I... |
Director |
• • • |
2013-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,161 |
2,673,522 |
0 |
- |
|
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2020-04-02 |
4 |
B |
$4.96 |
$35,792 |
I/I |
7,223 |
96,323 |
1.5 |
% |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
1,292,787 |
0 |
- |
|
148 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
